PUNE, India, July 27, 2018 /PRNewswire/ --
ReportsandReports added gene panels market research, it includes Illumina, Inc. (US), BGI (China), Agilent Technologies (US), Eurofins Scientific (US), QIAGEN (Germany), GENEWIZ, Inc. (US), Novogene Corporation (China), Personalis (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche AG (Switzerland), Integrated DNA Technologies (IDT) (US), GATC Biotech AG (GATC Biotech) (Germany), and ArcherDx (US) players.
Browse 86 Market Data Tables and 38 Figures spread through 140 Pages and In-depth TOC on "Gene Panel Market by Product & Service, Technique (Amplicon, Hybridization), Design (Predesign, Custom), Application (Cancer, Congenital Disease, Pharmacogenetics) & End User (Hospital, Research Center, Pharmaceutical Companies) - Global Forecast to 2023" at http://www.reportsnreports.com/reports/1517944-gene-panel-market-by-product-service-technique-amplicon-hybridization-design-predesign-custom-application-cancer-congenital-disease-pharmacogenetics-end-user-hospital-research-center-pharmaceutic-st-to-2023.html .
The global gene panels market is expected to reach USD 2.95 billion by 2023 from USD 1.22 billion in 2018, at a CAGR of 19.2%. This market is experiencing significant growth due increasing prevalence of chronic diseases, growing company initiatives (in terms of strategic partnerships, collaborations, and product launches), and growing adoption of gene panels owing to the benefits they offer.
The study estimates gene panels market size for 2018 and projects its demand till 2023. In primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative & quantitative information for report. Report provides an overview of gene panels market. It aims at estimating market size & future growth potential of this market across different segments like product & service, technique, design, application, end user, & region.
Download the Sample Brochure of "Gene Panel Market by Product & Service, Technique (Amplicon, Hybridization), Design (Predesign, Custom), Application (Cancer, Congenital Disease, Pharmacogenetics) & End User (Hospital, Research Center, Pharmaceutical Companies) - Global Forecast to 2023" Report Now at http://www.reportsnreports.com/contacts/requestsample.aspx?name=1517944 .
Gene panels market is segmented into predesigned and customized panels. The customized gene panels segment is expected grow at the highest CAGR during the forecast period. This growth is attributed to the evolving needs of the emerging therapeutic and diagnostic application sectors and the increasing number of clinical and preclinical research studies.
Target Audience for this Report:
- NGS equipment manufacturers, vendors, and distributors
- NGS sequencing services companies
- NGS bioinformatics/data analysis companies
- Research institutes and government organizations
- Venture capitalists and government funding organizations
- Research and consulting firms
- Healthcare institutions
- Pharmaceutical and biotechnology companies
- Contract manufacturing organizations
- Contract research organizations
North America is expected to account for the largest share of the market followed by Europe. North America is also projected to register the highest CAGR during the forecast period. This can be attributed to factors such as the government support for genomics research, presence of leading NGS providers, and growing research on cancer and inherited rare diseases in the region.
Place the Order on Global Gene Panel Market Research Report Now at http://www.reportsnreports.com/purchase.aspx?name=1517944 .
The large share of the North American market can be majorly attributed to the government support for genomics research. Other growth factors include the presence of leading NGS providers, growing research on cancer and inherited rare diseases, and increasing number of NGS-based & clinical applications in the region.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 - 30%; Tier 2 -42%; Tier 3 - 28%
- By Designation: C-level- 25%; D-level- 45%; Others- 30%
- By Region: North America-48%; Europe-29%;Asia Pacific-19%; Rest of the World-4%
Another research titled High-Throughput Screening Market is expected to reach USD 21.69 billion by 2023 from an estimated USD 14.87 billion in 2018, at a CAGR of 7.8%. The initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological developments in HTS, and the availability of government funding and venture capital investments are the factors driving the growth of the HTS market. The prominent players in the global HTS market are Agilent (US), Danaher (US), Thermo Fisher Scientific (US), PerkinElmer (US), Tecan (Switzerland), Axxam (Italy), Merck Group (Germany), Bio-Rad (US), Hamilton (US), Corning (US), BioTek (US), and Aurora Biomed (Canada) and it is now available with discount at http://www.reportsnreports.com/contacts/discount.aspx?name=274672
Explore More Reports on Biotechnology Market Research at http://www.reportsnreports.com/market-research/biotechnology/ .
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
2nd Floor, Metropole Building,
Next to Inox Theatre,
Bund Garden Road, Pune - 411001.
Connect with Us: